James Hamilton
Corporate Officer/Principal presso ARROWHEAD PHARMACEUTICALS, INC.
Patrimonio netto: 6 M $ in data 31/03/2024
Profilo
James C.
Hamilton is the founder of NanoValent Pharmaceuticals, Inc. (founded in 2005).
He is currently the Chief Discovery & Translational Medicine at Arrowhead Pharmaceuticals, Inc. He was formerly the Chief Executive Officer at Calando Pharmaceuticals, Inc. Dr. Hamilton received his undergraduate degree from Miami University and his MBA and doctorate degrees from The Ohio State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2024 | 204 851 ( 0.17% ) | 6 M $ | 31/03/2024 |
Posizioni attive di James Hamilton
| Società | Posizione | Inizio |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| NanoValent Pharmaceuticals, Inc. | Founder | 23/02/2010 |
Precedenti posizioni note di James Hamilton
| Società | Posizione | Fine |
|---|---|---|
Calando Pharmaceuticals, Inc.
 Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | President | - |
Formazione di James Hamilton
| Miami University | Undergraduate Degree |
| The Ohio State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | Health Technology |
| NanoValent Pharmaceuticals, Inc. |
- Borsa valori
- Insiders
- James Hamilton
